Liberia to get experimental Ebola drug to treat two doctors- minister
DAKAR Aug 12 (Reuters) - Liberia will receive enough of an experimental Ebola drug to treat just two infected Liberian doctors, Information Minister Lewis Brown said, after the U.S. Food and Drug Administration (FDA) approved its export.
Brown said Liberia's Health Ministry had contacted the U.S. manufacturer of ZMapp, Mapp Biopharmaceutical, and asked the FDA to quickly approve its export.
The doctors had consented in writing to the treatment, the minister said. (Reporting by Daniel Flynn, editing by John Stonestreet)
- Divided, Scots prepare to vote on fate of the United Kingdom |
- Dollar soars to six-year peak on yen after Fed, Tokyo stocks cheer
- Australian PM says police raids follow threat of beheading
- Apple to unveil new iPads, operating system on Oct. 21: report
- IMF warns of risks from 'excessive' financial market bets